1. Home
  2. AEE vs RMD Comparison

AEE vs RMD Comparison

Compare AEE & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameren Corporation

AEE

Ameren Corporation

HOLD

Current Price

$105.99

Market Cap

31.3B

Sector

Utilities

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$219.77

Market Cap

34.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEE
RMD
Founded
1901
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Medical/Dental Instruments
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.3B
34.0B
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
AEE
RMD
Price
$105.99
$219.77
Analyst Decision
Buy
Buy
Analyst Count
13
10
Target Price
$115.83
$292.56
AVG Volume (30 Days)
1.2M
1.2M
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.55%
1.13%
EPS Growth
21.04
9.67
EPS
2.41
10.43
Revenue
$8,799,000,000.00
$2,957,013,000.00
Revenue This Year
$7.17
$10.60
Revenue Next Year
$7.07
$7.41
P/E Ratio
$44.29
$21.19
Revenue Growth
15.43
13.44
52 Week Low
$96.57
$180.27
52 Week High
$117.39
$284.87

Technical Indicators

Market Signals
Indicator
AEE
RMD
Relative Strength Index (RSI) 41.03 43.86
Support Level $105.54 $218.39
Resistance Level $106.61 $222.43
Average True Range (ATR) 1.59 5.85
MACD 0.04 -2.44
Stochastic Oscillator 26.82 10.87

Price Performance

Historical Comparison
AEE
RMD

About AEE Ameren Corporation

Ameren owns rate-regulated generation, transmission, and distribution networks that deliver electricity and natural gas through the company's two main subsidiaries, Ameren Missouri and Ameren Illinois. It serves 2.5 million electricity customers and 900,000 natural gas customers across its two service territories.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: